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Abstract
Background: Transient receptor potential channel type 6 (TRPV6) and Calbindin-D9k (CaBP-9k) are involved in the
active calcium (Ca2+) transport mechanism in many tissues including placenta and uterus, suggesting a role in the
establishment and maintenance of pregnancy. Moreover, TRPV6 and CaBP-9k seem to support the materno-fetal
Ca2+ transport that is crucial for fetal Ca2+ homeostasis, bone growth and development. However, it is unknown if
these proteins are also involved in the aetiology of pathologies associated with parturition in cows, such as
retained fetal membranes (RFM). The aim of the current study was to create an expression profile of uterine and
placentomal TRPV6 and CaBP-9k mRNAs and proteins during pregnancy and postpartum in cows with and without
fetal membrane release.
Methods: Uteri and placentomes of 27 cows in different stages of pregnancy and placentomes of cows with and
without RFM were collected. Protein and mRNA expression of TRPV6 and CaBP-9k was investigated by real-time
PCR, immunohistochemistry and Western blot.
Results: In the uterine endometrium, highest TRPV6 and CaBP-9k expression was found in the last trimester of
pregnancy, with a particular increase of protein in the glandular epithelium. In the placentomes, a gradual increase
in TRPV6 mRNA was detectable towards parturition, while protein expression did not change significantly.
Placentomal CaBP-9k expression did not change significantly throughout pregnancy but immunohistochemistry
revealed an increase in staining intensity in the maternal crypt epithelium. Immunohistochemical, stronger placental
CaBP-9k signals were seen in animals with RFM compared to animals with an undisturbed fetal membrane release,
while protein levels, measured by Western blot analyses did not change significantly.
Conclusions: The results of the present study demonstrate a dynamic expression of TRPV6 and CaBP-9k during
pregnancy in the bovine uterine endometrium and placentomes, suggesting a functional role for these proteins in
Ca2+ metabolism during pregnancy. The temporal and spatial expression patterns indicate that TRPV6 and CaBP-9k
may be involved in materno-fetal Ca2+ transport, mainly through an interplacentomal transport, and that both
proteins may participate in physiological processes that are crucial for fetal and placental development. However,
neither TRPV6 nor CaBP-9k seem to be causative in the retention of fetal membranes.
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Background
The presence of Ca2+ in female reproductive tissues is
essential during pregnancy. Uterine Ca2+ ions are thought
to be involved in the establishment and maintenance of
pregnancy, possibly by controlling myometrial activity and
by influencing the secretion of extra-cellular matrix com-
ponents [1-3]. Furthermore, materno-fetal transport of
Ca2+ is crucial for fetal development, e.g. bone mineraliza-
tion, neuromuscular activities, and blood coagulation
[4,5]. In the placenta, Ca2+ functions as an important sec-
ond messenger that regulates several cellular processes
such as transcription, proliferation, differentiation, necro-
sis and apoptosis [6]. During pregnancy, the fetal require-
ment for Ca2+ increases strikingly, especially in the last
trimester of gestation: the Ca2+ content of bovine fetuses
increased from 3 g/kg at d 100 postmating to 8 g/kg at d
280, indicating a high level of materno-fetal Ca2+ transfer
[7]. This Ca2+ must be transported against a concentration
gradient from the mother to the fetus [8], thus an active
transport mechanism is required.
TRPV6 and CaBP-9k (also known as S100 calcium bind-
ing protein G) are crucial elements in the active transport
mechanism of mammals. TRPV6 is an epithelial Ca2+
channel, localized in the apical membrane of epithelial
cells in several tissues, including small intestine, kidney,
uterus and placenta [9], which mediates Ca2+ uptake into
the cell. CaBP-9k is known to facilitate intracellular Ca2+
transport from the apical to the basolateral cell membrane
and functions additionally as an intracellular buffer of Ca2+
in many tissues, such as intestine, bone, uterus and pla-
centa [10]. The expression, and to a certain extent, the
regulation of CaBP-9k and TRPV6 in female reproductive
tissues is well documented in several mammalian species,
such as rat, mouse, pig and human [5,11-14]. Unlike
in Ca2+-absorbing organs like the duodenum, where the
expression of these proteins is regulated mainly via vita-
min-D, their expression in the female reproductive system
seems to be regulated via the steroid hormones progester-
one and estrogens [2,11,12]. Interestingly, there are dis-
tinct variations in the expression and regulation of both
proteins among different mammals, which explains their
species-specific, dynamic expression patterns during the
estrous cycle and pregnancy [1,2,11].
The clinical importance of TRPV6 in female reproduc-
tive tissues has been shown using TRPV6-knockout mice
[4]. These animals showed reduced fertility, the materno-
fetal Ca2+ transport was 40% lower and fetal Ca2+ accu-
mulation was reduced compared to wild type mice. The
physiological role of uterine CaBP-9k appears to be the
regulation of myometrial activity, while in the placenta
CaBP-9k is thought to be involved in the regulation of the
materno-fetal Ca2+ transport [3,12].
Taken together, several findings indicate that TRPV6 and
CaBP-9k may play an important role in the establishment
and maintenance of pregnancy and the materno-fetal Ca2+
transport in mammals. Thus an undisturbed Ca2+ metabo-
lism in the reproductive tissues is crucial for fertility and
fetal health.
So far, however, the expression of uterine and placento-
mal TRPV6 expression has not been studied during preg-
nancy in the cow. Moreover, it is unknown if TRPV6 or
CaBP-9k are involved in the development of pathologies
related to pregnancy and parturition. The expression of
bovine CaBP-9k was investigated in the bovine uterus dur-
ing the estrous cycle [15], where it was mainly detected
during the luteal phase, and placentomal CaBP-9k was
examined in the second half of pregnancy, where its
expression level increased during the last trimester, corre-
lating with the increased fetal Ca2+ demand [16].
This study was performed to obtain further informa-
tion about the uterine and placentomal Ca2+ metabolism
at different stages of pregnancy in the cow. Therefore,
the temporal and spatial expression patterns of TRPV6
and CaBP-9k protein and mRNA in the uterine endome-
trium and in the placentomes were examined.
Retained fetal membranes (RFM) in cows are described
as an anomaly in the normal release of the fetal mem-
branes within 12 hours after calving [17]. The mechanism
leading to RFM is still unclear. Factors such as nutritional
deficiencies, inflammation of the placenta after parturi-
tion, disturbances in maturation of the fetomaternal unit
and in apoptotic processes have all been implicated in the
aetiology of RFM [18].
Since Ca2+ plays such an important role in many cellular
processes concerning placental maturation, such as prolif-
eration, differentiation, transcription or apoptosis [6], it is
also a matter of interest if TRPV6 and CaBP-9k may be
involved in the detachment of the placenta postpartum.
Therefore, this study further investigated the placental
expression of TRPV6 and CaBP-9k postpartum in animals
that discharged their fetal membranes within 12 hours
after parturition and animals that did not.
Methods
Animals
Uteri of 45 pregnant Holstein-Friesian cows were col-
lected at the local abattoir and three or four at each
month 2–9 of gestation were selected at random for the
present study. Within 30 minutes after the animals were
killed, they were eviscerated, the pregnant uteri were
opened and the crown-rump lengths of the 45 fetuses
were recorded to estimate fetal age as described by Boos
et al. [19].
The study also examined placental specimens of five
spontaneously calving postpartum cows that discharged
the fetal membranes (DFM) within 12 hours after expul-
sion of the fetuses and of five animals that retained fetal
membranes (RFM). These cattle were members of the
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university dairy herd or patients from the Clinic for
Bovine Obstetrics and Gynaecology, University of Veter-
inary Medicine Hannover, Foundation.
Animal experiments were approved by the administra-
tion of the district Hannover, and performed according
to the German Law for the Protection of Animals
(TierschG) and the recommendations of the German
Society of Laboratory Animal Science (GV-SOLAS).
Tissue sampling and processing
At the abattoir, at least two randomly selected and com-
paratively large placentomes and two segments of the
interplacentomal uterine wall including adherent allan-
tochorion were excised from each animal. Macroscopi-
cally visible caruncles, the adhering allantochorion and
the surrounding segment of the uterine wall were
excised from the uterine horn ipsilateral to the corpus
luteum in early pregnant cows. Only a single place tome
each -but no uterine wall- was collected from ten cows
within one hour after the expulsion of their calf. For
excision of placentomes from live cows, an elongated
effeminator according to Reisinger (1906), modified by
Richter (1936) (Hauptner, Solingen) was used.
A centrally located cross section of approximately
10 mm in thickness was performed on selected placen-
tomes. The sections were cut in pieces of 10x10mm and
three samples each were selected for further processing.
These were: (1) uterine wall oriented – concave side –
tissue cube, i.e., placental tissue including maternal plate
and placental stalk material; (2) allantoic sac oriented –
convex side – tissue cube, i.e., placental tissue including
fetal plate material, and finally (3) tissue cube collected
from the periphery – equatorial – also including fetal
plate and placental tissue. The specimens were oriented
and mounted in Tissue-Tek IIW (Miles, Elkhart, Ind.,
USA) on cork lamellae, snap frozen and stored at −80°C.
For immunohistochemistry, tissue samples were rinsed
in 0.9% saline, fixed in 4% neutral buffered formalin for
24 hours and finally embedded in paraffin (Histowax,
Leica) as previously described [19].
RNA isolation and quantitative real-time (Taqman) PCR
Total RNA from bovine uterine wall and placentomes
from the 2nd to 9th month of pregnancy (n= 3 animals /
month) and placentomes of postpartum cows with (RFM,
n= 5) and without retained fetal membranes (DFM, n= 6)
was isolated using TRIzol Reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. RNA
concentration was measured by spectrophotometry
(SmartSpecTM Plus Spectrophotometer, Biorad, Reinach,
Switzerland). Purity and quality of mRNA were deter-
mined by optical density (OD) measurement. The OD
260/280 ratio of all samples was greater than 1.8. Then,
200 ng of total RNA was DNase treated (DNase I recom-
binant, RNase free, Roche Diagnostics, Indianapolis, USA)
and reverse transcribed using the Gold RNA PCR Core
Kit (Gene Amp, Applied Biosystems, Foster City, CA).
The RT reaction was run for 8 minutes at 21°C, 15 minutes
at 45°C and 5 minutes at 99°C.
Real Time (Taqman) PCR was performed using the ABI
7500 Fast Real-Time PCR System (Applied Biosystems,
Rotkreuz, Switzerland), as described previously [20]. In
brief, samples were amplified in duplicates in a 25-μl
reaction mixture containing 12.5 μl FastStart Universal
Probe Master (Roche Diagnostics, Mannheim, Germany),
300 nM of each primer, 200 nM Taqman probe and 5 μl
cDNA. Autoclaved water instead of RNA and the
so-called RT minus control were used as negative
controls. Primers and 6-carboxyfluorescein (6-FAM)- and
6-carboxytetramethyl-rhodamine (TAMRA)-labelled probes
were designed using Primer Express Software (Applied
Biosystems) and ordered from Eurogentec, B-4102 Sera-
ing, Belgium. For primer and probe sequences see
Table 1. The expression levels of TRPV6 and CaBP-9k
were quantified by the comparative CT method, calcu-
lated relative to the expression of the reference gene
GAPDH and normalized to the calibrator. The sample
with the lowest level of the respective target gene tran-
scripts was used as the calibrator. The efficiency of the
PCR reactions was verified using the CT slope method
according to the instructions of the manufacturers of
Table 1 Sequences of primers and probes
Primer sequence Accession #
TRPV6 forward 5 -CAAGGAGCCCATGACATCTGA-3
TRPV6 reverse 5 -CAGGGCTTTCACGAGGTTCA-3 NM_001206189.1
TRPV6 probe 5 -CGGCCCTGCACATAGCAGTCATGAA-3
CaBP-9k forward 5 -TCTCCAGAAGAACTGAAGGGC-3
CaBP-9k reverse 5 -CCAACACCTGGAATTCTTCG-3 NM_174257.2
CaBP-9k probe 5 -TCCAAGCACCCTCGATGAGCTTTTTGA-3
GAPDH forward 5 -GCGATACTCACTCTTCTACCTTCGA-3
GAPDH reverse 5 -TCGTACCAGGAAATGAGC TTGAC-3 NM_001034034.1
GAPDH probe 5 -CTGGCATTGCCCTCAACGACCACTT-3
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the ABI 7500 Fast Real-Time PCR System. The specifi-
city of the selected PCR products was confirmed by
sequencing (Microsynths, Switzerland).
Immunohistochemical analysis
Paraffin-embedded tissue samples were cut at 3 μm. Sec-
tions were dew axed using xylol and rehydrated through
serial dilutions of ethanol to water and rinsed in water.
Antigen retrieval was performed by boiling the sections
in 10 mM citrate buffer pH 6.0 in a microwave oven
(600 W, 3 x 5 minutes) and rinsing in Tris-buffered
saline (TBS, buffer stock solution: 6.1 g Trizma base,
50 ml H20 and 37 ml 1 N HCl, diluted with H2O to
1000 ml solution, pH adjusted to 7.6; working solution:
100 ml buffer stock solution plus 900 ml 0.85% saline).
Endogenous peroxidase activity was inhibited by incu-
bating the sections in 0.3% H2O2 in methanol for 15 min-
utes. Non-specific binding was blocked with 10% normal
goat serum. The tissue sections were incubated at 4°C
overnight with the primary antibody. The expression of
TRPV6 was detected with a rabbit polyclonal anti-
TRPV6 antibody (ACC-036, Alomone Labs, Israel) at
a 1:200 dilution, which reacts with the intracellular
C-terminus. The expression of CaBP-9k was detected
with a rabbit polyclonal anti-CaBP-9k-antibody (Swant,
Bellinzona, Switzerland) at a dilution of 1:5000, which was
produced against rat recombinant Calbindin-D9k protein.
As negative controls, tissue sections were incubated with
an isotype specific rabbit IgG (Vector Laboratories,
Burlingame, CA, USA) and with TBS instead of the
primary antibody.
After rinsing in TBS for 3x10 minutes, the biotinylated
secondary antibody (PowerVision Poly-HRP IHC Detection
System, goat anti-Rabbit IgG) was added in dilution of
1:200 and sections were incubated for 30 minutes at 23°C.
After washing in TBS for 2x10 minutes, the tissue sections
were incubated for 30 minutes with StreptABComplex/
HRP Duett (Dako, Glostrup, DK), and Chromogen diami-
nobenzidine tetrahydrochloride (Liquid DAB+Substrate,
Dako, Baar, Switzerland) was added. Before being automa-
tically coverslipped (RCM 2000W; Medite) in PertexW
(Medite), the sections were counterstained with
haematoxylin.
Western blot
The tissue samples (n= 3 animals/month) were homoge-
nised in NET-2 buffer (50 mM Tris–HCl, pH 7.4, 300 mM
NaCl, 0.05% Nonidet P-40 [21] containing 1 μl/ml pro-
tease inhibitor (Sigma-Aldrich, Buchs, Switzerland) and
centrifuged (1000 g) for 10 minutes at 4°C. The clarified
supernatants were removed, and the protein concentra-
tions were determined by the Bradford method (Bradford,
1976) (Bio-Rad Laboratories, Reinach, Switzerland). Sam-
ples were diluted with NET-2 buffer and sample buffer,
containing β-mercaptoethanol, and incubated for 5 min-
utes at 95°C.
Proteins were separated on SDS-Gel (TRPV6: 10%
polyacrylamide, CaBP-9k: 12% polyacrylamide) and
transferred onto PVDF membranes. For the deglycosyla-
tion of TRPV6, the proteins were denatured at 100°C
and incubated with N-glycosidase F (PNGase F, New
England Biolabs, Frankfurt, Germany) at 37°C for 1 hour,
before separation by SDS-Gel, according to the manu-
facturer’s protocol. After blocking the membranes in 5%
fat-free milk in PBS-T (Tris-buffered saline with 0.025%
Tween-20) for one hour, the membranes were incubated
overnight at 4°C with the primary antibodies diluted in
2.5% milk/PBS-T. The antibodies were identical to those
used for immunohistochemistry, diluted 1:500 (TRPV6)
and 1:5000 (CaBP-9k). As a negative control for the
TRPV6 antibody, samples were preincubated with a spe-
cific control antigen (Alomone labs, Israel).
Afterwards, the blots were washed in PBS-T three
times for 10 minutes and incubated with the secondary
peroxidase-conjugated antibody for one hour at 23°C
(anti-rabbit IgG (H+ L) HRP conjugate, Promega,
Dübendorf, Switzerland). Membranes were washed five
times in PBS-T for 10 minutes. Protein detection was
performed by chemiluminescence (Immun-Star HRP
Substrate Kit, Bio-Rad) and exposed to LAS-3000 (Fuji-
film). The membranes were reblotted with anti-GAPDH
antibody at a 1:5000 dilution as the loading control. The
optical density of the TRPV6, CaBP-9k and GAPDH
bands was quantified using ImageJ software. The values
are presented as the ratio of TRPV6 and CaBP-9k
optical density to the corresponding GAPDH optical
density.
Statistics
The data sets of real-time and Western blot were tested
for normality using the Kolmogorov-Smirnov Test [22].
Small deviations from normality were observed in the
dataset of CaBP-9k mRNA expression in the placenta.
Therefore, these data were analyzed by a nonparametric
one-way analysis of variance using the Kruskal-Wallis
test, followed by Dunn`s post test. The remaining data-
sets were analyzed using a parametric one way analyses
of variance (ANOVA) followed by Dunnetts comparison
test, where the second month was taken as the control
group. Real-time and Western blot data sets of animals
with retained fetal membranes in comparison to animals
that discharged the fetal membranes were analyzed by
an unpaired one-tailed t-test. For all of the statistical
analyses, the software programme GraphPad Prism 5.0
(GraphPad Software Inc., San Diego, CA, USA) was
used. P < 0.05 was considered statistically significant.
Data are presented as means ± SD.
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Results
Expression of TRPV6 and Calbindin-D9k mRNA in the
uterus and placenta during pregnancy
TRPV6 and CaBP-9k mRNA expression in the uterine
wall and in the placentomes from the 2nd to 9th months
of pregnancy was investigated by quantitative real-time
(Taqman) PCR. In the uterine wall, TRPV6 mRNA was
detected throughout pregnancy with the highest levels in
the 7th and 8th months (p < 0.05) (Figure 1A). Placental
TRPV6 expression levels increased from the 2nd month
to the highest levels in the 7th, 8th and 9th months of
pregnancy (p < 0.05) (Figure 1B).
Interplacentomal uterine CaBP-9k mRNA expression
was detected throughout pregnancy with a significant
increase in the 7th and 8th months (p < 0.05) (Figure 1C).
In the placentomes CaBP-9k mRNA was detected
throughout the pregnancy without any significant
changes (p > 0.05) (Figure 1D).
Localisation of TRPV6 protein in the uterus and placenta
during pregnancy
Immunohistochemistry was performed to determine the
localization of TRPV6 in the uterine intercaruncular wall
and in the placentomes during pregnancy (Figures 2, 3).
In the uterus TRPV6 protein was detected in the lumi-
nal and in the glandular epithelium and revealed the
strongest labelling in the glandular epithelium in the
3rd month and from the 7th month until parturition
(Figure 2).
In the placenta, TRPV6 was primarily expressed in the
inner layer of the placentomes throughout pregnancy.
Considerably lower staining was found in the middle
and outer layers of the labyrinth (Figures 3A, D). Stron-
gest labelling was seen in the adherent fetal membranes
(Figure 3A, C). The distribution at the cellular level was
diffuse (Figure 3B).
Localisation of CaBP-9k protein in the uterus and
placenta during pregnancy
The localization of CaBP-9k in the uterine endometrium
and in the placentomes was investigated by immunohis-
tochemistry (Figures 4, 5). In the endometrium, CaBP-9k
was detected in the luminal and glandular epithelium.
The strongest staining intensity was visible in the gland-
ular epithelium of the 7th and 8th months of pregnancy
(Figure 4C, D). Furthermore the trophoblast epithelium
of the adherent fetal membranes was strongly stained
(Figure 4A, B).
Placental CaBP-9k protein was mainly detected in the
luminal, inner layer and in the fetal membranes
(Figure 5A, C). Staining intensity decreased towards the
outer labyrinth layer. On the cellular level, CaBP-9k was
expressed in the cytoplasm and nuclei of the maternal
crypt epithelium and in the uni- and binucleate fetal
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Figure 1 Uterine and placentomal TRPV6 and CaBP-9k mRNA expression. TRPV6 and CaBP-9k mRNA expression in the intercaruncular wall
(Figure 1A, C) and in the placenta (n≥ 3 animals/month) (Figure 1B, D) from the 2nd to 9th months of pregnancy, determined by real-time PCR.
Bars with ** differ significantly (p < 0.05) compared to the second month (*). Data were analysed using a parametric one-way analysis of variance
(ANOVA), followed by Dunnett’s comparison test and are presented as means ± SD. The nonparametric dataset of placental CaBP-9k was analysed
using the Kruskal-Wallis test, followed by Dunn`s post test.
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cells. The strongest staining was found in the binucleate
cells and in the maternal crypt epithelium. In the latter
the staining intensity increased towards parturition
(Figure 5B, D).
Western blot analyses of TRPV6 and CaBP-9k protein in
the uterus and placenta during pregnancy
In addition to the protein localization, the expression of
TRPV6 and CaBP-9k protein in the uterine wall and in
the placentomes was further investigated by Western
blot analyses (Figures 6, 7). In both the uterine and pla-
cental tissues, bands of TRPV6 with a molecular mass of
75 kDa were detected from the 2nd to the 9th months
without significant changes in expression levels (Figure 6).
In some animals a second band of approximately 90 kDa
was detected in the 2nd and/or 3rd months, which repre-
sents the glycosylated variation of TRPV6.
Bands of CaBP-9k protein with a molecular weight of
9 kDa were detected in the uterine and placental tis-
sues (Figure 7). The highest (p < 0.05) expression
levels were found in the uterine endometrium in the
7th month of pregnancy (Figure 7B). In the placenta,
no significant changes were detectable during pregnancy
(Figure 7D).
Expression and localization of TRPV6 and CaBP-9k in the
placenta post partum in cows with and without retention
of fetal membranes
The placental mRNA levels of TRPV6 and CaBP-9k of
animals that retained fetal membranes postpartum com-
pared to animals that discharged fetal membranes were
examined by real-time PCR. Neither the TRPV6 nor the
CaBP-9k expression levels showed significant differences
between the groups (p > 0.5) (Figure 8).
Immunolabelling of TRPV6 and CaBP-9k protein was
performed to localise these proteins in the placentomes
of animals that retained and animals that discharged the
fetal mambranes (Figures 9, 10). The strongest labelling
of both proteins was detected in the fetal membranes in
both groups. In the place tome, TRPV6 was found in the
BA
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Figure 2 Immunolabelling of TRPV6 in the uterine endometrium. Localisation of uterine TRPV6 during pregnancy with strong labelling in the
glandular (GE) and luminal epithelia (LE). Figure 2F shows a negative control, without anti-TRPV6 treatment. Scale bars indicate 200 μm.
Sprekeler et al. Reproductive Biology and Endocrinology 2012, 10:66 Page 6 of 13
http://www.rbej.com/content/10/1/66
maternal part of the place to me and in the trophoblast
cells of both groups (Figure 9B, D). Strong staining of
TRPV6 was found in the maternal crypt epithelium of
animals that retained their fetal membranes (Figure 9D).
Similar observations were made in the distribution of
CaBP-9k in the place to me. Besides the strong staining
in the fetal membranes (Figure 10A, C), strongest signals
were localized in the binucleate trophoblastic cells and
in the maternal crypt epithelium of cows that retained
fetal membranes (Figure 10D). The uninucleate cells
5th htnomht5htnom
ML
IL
OL
FM
5th month 7th month
A B
DC
FM
Figure 3 Immunolabelling of TRPV6 in the placentomes and adherent fetal membranes. Localisation of TRPV6 during pregnancy in the
placenta and adherent membranes with strong staining in the inner layer (IL) of the place tome (A, D) and the adherent fetal membranes (FM)
(A, C). Considerably weaker staining in the middle (ML) and outer labyrinth (OL) layers (A, B). Scale bars indicate 200 μm.
GE
3rd month 5th month
F
MLE
GE
GEF
M
LE
8th month7th month
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Figure 4 Immunolabelling of CaBP-9k protein in the uterine endometrium. Localisation of CaBP-9k in the glandular (GE) and luminal
epithelia (LE) during pregnancy (A-D). Strongest staining was detected in the fetal membranes (FM) (A, B). Scale bars indicate 200 μm.
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were also stained, but the intensity was considerably
weaker.
In the Western blot analyses, no significant differences
in TRPV6 and CaBP-9k expression were detected
between the groups (p > 0.5) (Figure 11).
Discussion
The results of the current study show for the first time
that TRPV6 is expressed in time- and cell type specific
patterns during different stages of pregnancy in the uter-
ine endometrium and placentomes in the cow, indicating
a functional role for this protein in Ca2+ metabolism dur-
ing pregnancy. Furthermore, the expression patterns of
CaBP-9k as an important intracellular Ca2+ transporter
and buffer were investigated to check for possible colocali-
zation and functional correlation between both factors.
In other species, such as rodents and pigs, TRPV6
seems to participate in the implantation process, in the
maintenance of pregnancy, in the fetal Ca2+ supply and
in fetal development [1,2,4,11]. CaBP-9k may play a
major role in the implantation process, in the regulation
of myometrial activity and in the regulation of materno-
fetal Ca2+ transport [12,23,24]. The expression of CaBP-
9k in the bovine endometrium and placentomes has
been described previously [16,25], however, it has not
been shown to correlate with TRPV6 expression nor
with pathological conditions such as fetal membrane
retention.
In the current study, uterine expression of both
TRPV6 and CaBP-9k mRNA was highest in the 7th and
8th months of pregnancy, the time of enhanced fetal
growth and skeletal mineralization [7]. The localization
of both proteins in the glandular and luminal uterine
epithelium indicates an increase in Ca2+ transport through
or demand within these epithelia, which is met by high
expression of TRPV6 and CaBP-9k.
Ca2+ plays a key physiological role in many cellular
processes, including in secretory and exocytose processes
3rd month
IL
OL
3rd month
BNC ME
FM
Neg. control
IL
7th month
A B
DC
7th month
E
Figure 5 Immunolabelling of CaBP-9k in placentomes and adherent fetal membranes. Localisation of CaBP-9k during pregnancy with
strong signals in the inner layer (IL) of the place tome and in the fetal membranes (FM) compared to the outer labyrinth layer (OL) (A, C). Strong
staining in the binucleate trophoblast cells (BNC) and in the maternal epithelium (ME) inside the place tome (B, C). Figure 2F shows a negative
control, without anti-TRPV6 treatment. Scale bars indicate 200 μm.
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[26], so the increased demand in the glandular and
luminal epithelia may correlate with the secretory activity
of the epithelial cells. The glandular and luminal epithelia
are responsible, among other functions, for the production
and secretion of histiotrophe, which is essential for fetal
development [27] and growth. Thus, the localization and
the expression of TRPV6 and CaBP-9k in the uterine
endometrium, mainly in the last trimester which is the
time of enhanced fetal growth, indicate a functional role
in secretory activities and therefore in fetal nourishment
and development.
This idea is further supported by the high expression
of TRPV6 and CaBP-9k in the fetal membranes, indicat-
ing a high interplacentomally active Ca2+ transport into
the fetus, which previously has been demonstrated in-
vitro by Using-chamber studies in sheep [28]. The colo-
calization of both proteins suggests a functional correla-
tion between TRPV6 and CaBP-9k in the bovine
endometrium, which is well documented for other
epithelia such as the small intestine [29].
In the present study, the results of the Western blot
analyses did not show any significant time-dependent
changes in the expression of either of the proteins with
the exception of uterine CaBP-9k. Moreover, distinct
individual variations were detected between animals at
the same stages of pregnancy, as evidenced by the high
standard variations (SD) of the data obtained. The
immunohistochemistry results illustrate that the mea-
sured protein (and mRNA) levels are very dependent on
the anatomical composition of the samples taken for the
Western blot analyses and that even small changes in
anatomical structure and composition can be responsi-
ble for these variations. This could also be a reason for
the divergence between the measured mRNA and pro-
tein levels, particularly since the results of the immuno-
histochemistry demonstrate increased protein expression
in the 7th and 8th months. Nevertheless, the Western
blot data show a clear trend of expression patterns and
provide additional useful information. Furthermore, the
antibody used for the TRPV6 Western blot analyses
detected two proteins of approximately 75 and 90kDA.
Since TRPV6 is a glycoprotein [30], analyses of glycosy-
lation were performed. After incubation in the presence
of N-glycosidase F, only the smaller variation of 75 kDa
was detectable, demonstrating that the 90 kDa band
represents the glycosylated variation of TRPV6. Inside
the place tome, TRPV6 was mainly expressed in the
luminal, inner layer of the labyrinth. While a gradual
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Figure 6 Western blot analyses of endometrial and placentomal TRPV6 protein during pregnancy. A) Representative Western blot of
TRPV6 protein expression in the uterine wall (n = 3 animals/month). Bands of approximately 75 kDa were detected. An additional band of
approximately 90 kDa was seen in the 2nd and 3rd months. After incubation with N-glycosidase F (PNGase F), only the smaller band of 75 kDa
was seen, demonstrating that the other band is the glycosylated variant of TRPV6. As a negative control, samples were preincubated with a
control antigen. B) Relative expression of TRPV6 to GAPDH was determined by densitometry using ImageJ software. No significant changes were
detected (p > 0.05). C) Representative Western blot analyses of TRPV6 in the placenta from 2nd to 9th months of pregnancy (n = 3 animals/month).
D) The expression of TRPV6 relative to GAPDH was determined by measuring the optical density using ImageJ software. No significant changes
(p > 0.05) were detected. Data were analysed using a parametric one-way analysis of variance (ANOVA), followed by Dunnett’s comparison test,
where the second month was taken as the control group, and are presented as means ± SD.
Sprekeler et al. Reproductive Biology and Endocrinology 2012, 10:66 Page 9 of 13
http://www.rbej.com/content/10/1/66
increase in placental TRPV6 mRNA was found towards
parturition, the protein expression levels did not change
significantly throughout pregnancy. A possible role for the
discrepancy between mRNA and protein levels may be
post-transcriptional regulation, or the above-mentioned
possibility of small divergences in anatomical structure. A
similar placental increase of TRPV6 mRNA was described
in rats [2], while mouse placental TRPV6 expression peaks
in the middle but not at the end of pregnancy [1]. The
expression patterns of TRPV6 in the bovine placenta
indicate an influence on placental Ca2+ metabolism, but
their precise function remains unclear.
The considerably higher expression of TRPV6 protein
in the interplacentomal fetal membranes compared to
its expression in the placentomes provides evidence that
materno-fetal Ca2+ transport occurs mainly in the inter-
placentomal regions and TRPV6 seems to play a crucial
role in this process in the cow. Similar results are docu-
mented in mice, where the intra- and extra-placental
yolk sac is described to be the site of materno-fetal
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Figure 7 Western blot analyses of endometrial and placental CaBP-9k protein during pregnancy. A) Representative Western blot of
CaBP-9k in the uterine wall (n = 3 animals/month). Bands of approximately 9 kDa were detected. B) The highest expression relative to GAPDH was
found in the 7th month of pregnancy, determined by measuring the optical density using ImageJ software. Bars with ** differ significantly
(p < 0.05) compared to the 2nd month (*). C) Representative Western blot of CaBP-9k in the placenta (n = 3 animals/month). D) Relative expression
levels of CaBP-9k to GAPDH were determined by densitometry using ImageJ software. Significant changes in the expression levels were not
detected (p > 0.05). Data were analysed using a parametric one-way analysis of variance (ANOVA), followed by Dunnett’s comparison test, where
the second month was taken as the control group, and are presented as means ± SD.
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Figure 8 Placental TRPV6 and CaBP-9k mRNA expression post partum in cows with and without retained fetal membranes. Detection of
TRPV6 (A) and Calbindin-D9k (CaBP-9k) (B) mRNA levels in the placenta of postpartum cows that retained the fetal membranes for more than
12 hours (RFM; n = 5) and cows that discharged the fetal membranes (DFM; n = 6), measured by real-time PCR (Taqman). No significant changes
were observed (p > 0.05). Data were analyzed by an unpaired one-tailed t-test and are presented as means ± SD.
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Ca2+ transport in which TRPV6 seems to be a crucial
element [4].
The high expression of CaBP-9k and the colocalization
with TRPV6 in the fetal membranes supports this
theory. It has been demonstrated in earlier studies
that CaBP-9k levels in the ruminant interplacental
trophoblasts are eight to ten times higher than in the
placentomal region [25], which confirms our results
and supports the idea of a facilitated diffusion of Ca2+
through the fetal membranes to supply the enhanced fetal
need for Ca2+, especially in the last trimester of
pregnancy.
DFM
FM
DFM
RFM RFM
FM
A B
DC
ME
Figure 9 Localisation of TRPV6 protein in the placentomes and fetal membranes in cows with (RFM) (C, D) and without retained fetal
membranes (DFM) (A, B). Strongest labeling of TRPV6 protein was seen in the fetal membranes (FM) of all animals and in the maternal crypt
epithelium (ME) of cows with RFM (D).
BA
C D
MFDMFD
FM
RFM RFM
ME
FM
Figure 10 Localisation of placental CaBP-9k protein post partum in cows with (RFM) (C, D) and without retained fetal membranes
(DFM) (A, B). Strong staining was detected in the fetal membranes (FM) of all investigated animals and in the maternal crypt epithelium (ME) of
animals with retained fetal membranes (D) and in the binucleate trophoblast cells (BNC) of all animals.
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The intraplacetomal distribution of CaBP-9k, mainly
at the luminal side of the labyrinth, correlates with
TRPV6 localization, but on the cellular level there are
distinct variations. CaBP-9k is mostly expressed in the
binucleate trophoblast cells (BNC), as described pre-
viously [16] and in the maternal crypt epithelium, while
the distribution of TRPV6 is more diffuse. Interestingly,
the staining intensity of CaBP-9k in the maternal epithe-
lium increases towards parturition. The distribution of
CaBP-9k and its changes indicate a functional role in
placentomal Ca2+ metabolism. As described before, Ca2+
is important for many cell physiological processes, which
are also crucial for placental development and degrada-
tion [6]. Thus, the high expression of CaBP-9k in the
binucleate trophoblast cells may reflect the intracellular
need for Ca2+ to support the active metabolism of these
cells. In the ruminant placenta, the BNCs are, among
other cells, responsible for the synthesis of hormones
and proteins, for migration and cell-cell-interactions
[31], all processes which are Ca2+ dependent [32,33].
Furthermore, the high CaBP-9k expression in the mater-
nal crypt epithelium possibly reflects the increased Ca2+
requirement for cell-specific processes, such as integrin-
mediated placentation, placental growth and placental
maturation [19]. The important role of intracellular Ca2+
as a mediator of processes concerning placental matura-
tion in the last trimester, such as degradation, apoptosis
and separation, may explain the increase of CaBP-9k
expression by the maternal epithelium in the last trimester
of pregnancy. Based on this theory, it is possible that dis-
turbed Ca2+ cell metabolism influences maturation of the
placenta and apoptotic degradation of the maternal crypt
epithelium, which could lead to a disturbance in release of
the fetal membranes after parturition [19,34]. Therefore,
this study further examined the expression patterns of
TRPV6 and CaBP-9k in animals that retained the fetal
membranes compared to animals that discharged the fetal
membranes within 12 hours after parturition. In the
placentomes, both proteins were mainly detected in the
maternal epithelium, CaBP-9k additionally in the tro-
phoblast cells, especially in the binucleate cells. This loca-
lization explains the higher expression in animals that
retained the fetal membranes, since the maternal epithe-
lium is largely intact in these animals while it is strongly
reduced in cows with normal fetal membrane release.
Thus, the idea that a deficiency of TRPV6 or CaBP-9k
expression leads to a disturbance in release of fetal mem-
branes could not be confirmed. Expression of both pro-
teins reflects the status of the epithelia involvement and is
rather a consequence than the cause of the retention of
fetal membranes.
Conclusions
The results of the present study demonstrate for the first
time that TRPV6 is dynamically expressed in the bovine
uterine endometrium and in the placentomes during
pregnancy, indicating a functional role in Ca2+ metabo-
lism during gestation.
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Figure 11 Western blot analyses of placental TRPV6 and CaBP-9k postpartum in cows with (RFM) and without retained fetal
membranes (DFM). A) Representative Western blot of TRPV6 in the placenta. Bands of approximately 75 kDa were detected in all animals. B)
Relative expression of TRPV6 was determined by measuring the optical density relative to GAPDH using ImageJ software. Significant changes in
expression levels were not detected (p > 0.05). C) Representative Western blot of CaBP-9k. D) The relative expression levels to GAPDH were
determined by densitometry using ImageJ software. No significant changes were detected (p > 0.05). Data were analyzed by an unpaired
one-tailed t-test and are presented as means ± SD.
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The expression of TRPV6 and CaBP-9k in the uterine
glandular epithelium, in the placental maternal epithe-
lium and the fetal chorionic membranes suggests that
these proteins are involved in materno-fetal Ca2+ trans-
fer mainly through interplacental transport, especially in
the last trimester of pregnancy, a time of enhanced fetal
growth. Their distinct expression in the uterine glandu-
lar epithelium indicates that TRPV6 and CaBP-9k parti-
cipate in uterine secretory processes, which are crucial
for fetal nourishment and development.
Due to their increased expression in the maternal
epithelium and in the binucleate trophoblastic cells in
the placentomes, TRPV6 and CaBP-9k may function as
important elements in controlling placental develop-
ment, maturation and degradation through the regula-
tion of intracellular Ca2+ metabolism. However, neither
TRPV6 nor CaBP-9k seem to be causative in the reten-
tion of fetal membranes.
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